Hospital readmissions remain one of the most persistent problems in care delivery. A patient goes home, something slips in the first few weeks, and they are back in a bed. Each return is hard on the patient and the family. It also pulls staff and capacity away from other people who need them.
Remote patient monitoring (RPM) gives care teams a way to see those first weeks at home. This article covers the current readmission data, how CMS measures it, what new research says, and how teams use RPM to reduce hospital readmissions in practice. It closes with answers to the questions providers ask most often.
Why Programs Set Out to Reduce Hospital Readmissions
Efforts to reduce hospital readmissions start with the scale of the problem. According to AHRQ, U.S. hospitals recorded about 3.8 million 30-day all-cause adult readmissions in a single year. The average readmission rate was 14 percent. The average cost per readmission was $15,200. Medicare accounted for six in ten of those stays.
Four conditions drove one in five readmissions: septicemia, heart failure, diabetes, and COPD. Three of those are chronic conditions that tend to worsen gradually. Heart failure patients covered by Medicaid had a readmission rate of 28 percent. That is the window where remote patient monitoring has the most to offer.
The pattern is familiar to anyone who works in discharge planning. A patient with heart failure gains a few pounds of fluid over four days. A patient with COPD sees oxygen saturation drift down before the shortness of breath becomes obvious. Blood pressure climbs after a medication change that didn’t take. None of these changes show up at a follow-up visit three weeks out. They show up at home, between visits, when nobody is watching.
How CMS Measures Readmissions in 2026
The Hospital Readmissions Reduction Program (HRRP) is the Medicare program that ties hospital payment to 30-day readmission performance. CMS tracks unplanned readmissions for six conditions and procedures: acute myocardial infarction, heart failure, pneumonia, COPD, elective hip or knee replacement, and coronary artery bypass graft surgery. Hospitals with more readmissions than expected for their peer group see a reduction in Medicare inpatient payments. The maximum reduction is 3 percent.
For fiscal year 2026, CMS data showed roughly three in four eligible hospitals facing some penalty. About 240 hospitals, or 8 percent, lost 1 percent or more. Most penalties stayed below 1 percent.
Two changes arrive in fiscal year 2027. CMS will begin including Medicare Advantage enrollees in the readmission measures, not only traditional Medicare patients. CMS will also shorten the performance window from three years to two, so recent results carry more weight.
The patient side of this matters more than the payment side. MedPAC found that readmission rates declined after the program began and that mortality after discharge did not rise. Fewer return trips to the hospital means more recovery at home. That is the outcome a readmission program should be built around.
What the Research Says About RPM and Readmissions
Evidence on remote patient monitoring after discharge has grown considerably since this article was first published. Here is a summary of the strongest recent findings.
A 2026 Meta-Analysis of 160,000 Patients
A systematic review and meta-analysis in the Journal of Hospital Medicine pooled 39 studies, including 23 randomized controlled trials, covering 160,857 discharged adults. Patients who used remote biometric sensing devices after discharge had a 25 percent lower risk of all-cause readmission. Within 30 days of discharge, the risk was 26 percent lower. The same group had a 37 percent lower risk of death at 30 days. Post-surgical patients saw an 18 percent reduction in readmissions.
The authors call for more validation, as any careful review should. Still, this is the largest pooled analysis to date, and its direction is clear.
Geisinger’s Post-Discharge Program
A study in The Permanente Journal looked at a Geisinger RPM program that enrolled high-risk patients after discharge. Enrolled patients had a 30-day all-cause readmission rate of 11 percent. Patients who did not enroll had a rate of 41 percent. The sample was not randomized, so patient selection likely explains part of the gap. A 30-point difference is still worth attention.
Heart Failure and COPD
Heart failure has the deepest body of evidence for RPM. Daily weight and blood pressure readings give clinicians a chance to adjust diuretics before fluid builds to the point of admission. Our review of heart failure readmissions covers the major trials in detail.
COPD programs show a similar pattern. Pulse oximetry and symptom tracking at home surface early exacerbations. Programs that monitor COPD patients have reported large drops in unplanned hospitalizations in the year after enrollment.
Where Results Are Mixed
Not every population responds the same way. The ACCOMPLISH trial in JAMA Network Open tested remote monitoring after hospitalization for sepsis and lower respiratory tract infection. It found no overall gain in days at home. Among patients 65 and up, readmissions were higher with monitoring than with usual care.
The lesson is not that RPM fails. It is that monitoring after an acute infection is a different problem than monitoring a chronic condition that drifts over days. Program design has to match the patient. Our research update on reduced hospitalizations explores these differences in more depth.
How Remote Patient Monitoring Works After Discharge
Remote patient monitoring connects a patient at home to the care team responsible for their recovery. The devices are FDA-cleared and familiar: a blood pressure monitor, a weight scale, a pulse oximeter, a blood glucose meter. A patient takes a reading. The reading travels to the care team’s clinical platform. A nurse or care coordinator reviews it, often the same day.
The devices themselves fall into two groups. Standalone cellular devices have their own SIM card and send readings on their own. Bluetooth devices pair with a hub, such as the Tenovi Cellular Gateway, that forwards the readings. Either way, the patient does not need a smartphone, an app, or home Wi-Fi. That matters for rural patients and for anyone who finds pairing a device frustrating. A full list of RPM devices is available on our site.
The data creates the opportunity. The care team’s response creates the result.
Six Ways RPM Helps Reduce Hospital Readmissions
The programs that reduce hospital readmissions tend to share the same practices. Research and real-world results point to six.
- Enroll at discharge. The first two to four weeks after a hospital stay carry the highest readmission risk. Programs that hand a patient a device before they leave, or ship one to arrive the next day, cover that window. Enrolling three weeks later misses most of it.
- Monitor the right conditions. Heart failure, COPD, hypertension, and diabetes change gradually enough for a trend to show up before a crisis. Those are the conditions where RPM evidence is strongest. Acute infections and surgical recovery need a different model.
- Review readings every day. A reading nobody looks at cannot prevent anything. Successful programs assign clinical staff to review data seven days a week and define thresholds that trigger a call.
- Act fast on alerts. When a heart failure patient’s weight climbs three pounds in two days, someone calls the same day. The call may lead to a medication change, a same-week visit, or reassurance. Each of those is better than an emergency department visit on day five.
- Reconcile medications early. Medication errors after discharge are a leading cause of readmission. Daily readings often reveal a prescription that isn’t working or isn’t being taken. RPM gives the care team a reason to ask.
- Keep the patient involved. Patients who understand why they are taking readings stay engaged longer. Simple devices, a short setup call, and regular check-ins keep adherence high. Caregivers help, too.
Benefits for Patients and Care Teams
For patients, the benefit of avoiding a readmission is plain. Recovery continues at home. Strength is not lost to another week in a bed. The risk of a hospital-acquired infection or a fall goes down. Many patients also describe the monitoring itself as reassuring. Someone is watching, and they know who to call.
For care teams, remote patient monitoring changes where attention goes. Instead of waiting for a patient to call with symptoms, clinicians see which patients are drifting and reach out first. Automated data collection removes manual tracking. Alerts sort the day. A nurse managing a panel of post-discharge patients can focus on the four who need a call rather than the forty who are fine.
For health systems and payers, fewer avoidable readmissions ease pressure on inpatient capacity and improve the quality measures CMS tracks. Those gains follow from the patient outcome. They do not replace it.
Frequently Asked Questions About How to Reduce Hospital Readmissions With RPM
Providers and program leaders considering remote patient monitoring to reduce hospital readmissions often have practical questions. This section answers six of the most common ones, covering timing, conditions, evidence, devices, and what makes a program work.
1) How does remote patient monitoring reduce hospital readmissions?
It gives the care team daily readings during the weeks after discharge when risk is highest. Clinicians can spot weight gain, falling oxygen levels, or rising blood pressure early and intervene with a call, a medication change, or a visit before the patient needs the emergency department.
2) Which conditions have the strongest evidence for reduced readmissions?
Heart failure has the most extensive evidence, including large randomized trials and meta-analyses. COPD, hypertension, and post-surgical recovery also show reductions. Conditions that worsen gradually over days respond best because the trend is visible before symptoms become severe.
3) How soon after discharge should RPM start?
As soon as possible, ideally at discharge or within a day or two. Most readmissions occur within the first few weeks. Programs that enroll patients at the bedside or ship a device to arrive the next day cover the period of highest risk.
4) Does the research show RPM works for every patient?
No. A 2026 randomized trial in patients recovering from sepsis found no overall benefit and higher readmissions among patients 65 and up. Program design should match the condition, the patient, and the response the care team can deliver.
5) What devices are used to reduce hospital readmissions with RPM?
Blood pressure monitors, weight scales, pulse oximeters, and blood glucose meters are the most common. Cellular-connected devices send readings automatically without an app, Wi-Fi, or Bluetooth pairing. That simplicity keeps adherence high, especially for patients who are recovering and tired.
6) What does the care team need to make RPM work?
Daily review of incoming data, clear thresholds that trigger action, and a defined owner for each alert. The device collects the reading. A clinician who sees it and acts on it is what prevents the readmission.
Understanding How to Reduce Hospital Readmissions With Remote Patient Monitoring
Readmissions remain common, costly, and hard on patients. About 3.8 million adults return to the hospital within 30 days each year, and CMS now ties payment for six conditions to readmission performance. Remote patient monitoring addresses the weeks at home where most readmissions take shape. A 2026 meta-analysis of 160,000 patients found a 26 percent lower 30-day readmission risk with home monitoring devices. Programs at Geisinger and elsewhere report larger gaps. Results depend on enrolling at discharge, choosing the right conditions, reviewing data daily, and acting fast. Where those pieces are in place, RPM helps patients recover at home and helps care teams reach the right person at the right time.
Tenovi provides cellular-connected remote patient monitoring and remote therapeutic monitoring devices, fulfillment, and data integration for RPM software companies, care management companies, telehealth platforms, health systems, payers, and pharmacies. Our devices deliver reliable readings from patients at home so care teams can act early. Contact us for a free demo and consultation to see how Tenovi can support your readmission program.
